SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CARDIEX LIMITED (CDX)

Listed on ASX

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

Shareholder links

Our website ranking of CDX: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services, Rhodes Corporate Park, 1A Homebush Bay Drive, Rhodes NSW 2138

Tel : +61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000015729
Address: Suite 303, Level 3 15 Lime Street Sydney NSW 2000 AUSTRALIA
Tel:  (02) 9874 8761 Fax: (02) 9874 9022

Date first listed: 09/11/2005
Company Secretary: Jarrod White
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: The development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management

The suspension of trading in the securities of Cardiex Limited will be lifted immediately following the release by CDX of an announcement regarding its progress in relation to a joint development agreement with a partner organisation.

24/04/2020

ATCOR has this week completed a significant milestone in its engineering & technology program and has derived a series of unique and heart and arterial health features from a PPG sensor based on the Company's core SphygmoCor technology. Significant technology development milestone of wearable sensor technology for clinical and consumer applications. Technology will aim to assist in effective remote diagnosis and monitoring of hypertension and cardiovascular disease. Results to be shortly presented to ATCOR wearables partner Mobvoi, Google's official partner in China for Google's Wear OS platform. ATCOR has also been requested to demonstrate results to several major consumer wearable & technology companies.

24/04/2020

The securities of Cardiex Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of CDX, pending the release of an announcement regarding its progress in relation to a joint development agreement with a partner organisation.

22/04/2020

The suspension of trading in the securities of CardieX Limited will be lifted immediately following the release by CDX of an announcement regarding a customer contract.

18/06/2019

The company has determined that the GEMDC customer contract is material to inHealth but is not currently material to CardieX. The basis of this decision is by virtue of CardieX's current equity position in inHealth (7.7%), which is prior to conversion of the currently subscribed tranche 2 convertible note, that will increase CardieX's position to 41.03% prior to the tranche 3 option to increase this stake to 50.5%.

18/06/2019

The securities of CardieX Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of CDX, pending the release of an announcement regarding a customer contract.

17/06/2019

name changed from Atcor Medical Holdings Limited

18/06/2018

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    25/09/2013Michael O'Rourke-100,000$0.170$17,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Niall CairnsNon Exec Chairman20/12/2017
    King NelsonIndependent Director14/10/2015
    Michelle AlencarNon Exec Director01/02/2019
    Aubrey JenkinsNon Exec Director01/02/2019
    Craig CooperExecutive Director, CEO01/12/2017
    Jarrod WhiteDirector, CFO31/03/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Donal O'DwyerNon Exec Chairman09/11/200526/02/2019
    Duncan RossCEO09/11/200601/07/2018
    David BrookesNon Exec Director04/11/200803/04/2018
    Peter ManleyCFO01/03/200531/03/2018
    Michael O'RourkeNon Exec Director06/11/200530/11/2017
    Peter JenkinsNon Exec Director09/11/200513/11/2015
    Lisa McIntyreNon Exec Director04/11/2008
    Ross HarricksExecutive Director14/11/2007

    Date of first appointment, title may have changed.